Back to Search Start Over

Mucosal-associated invariant T cells are functionally impaired in pediatric and young adult patients following allogeneic hematopoietic stem cell transplantation and their recovery correlates with clinical outcomes

Authors :
Federica Galaverna
Sara Flamini
Carmen Dolores De Luca
Ilaria Pili
Emilia Boccieri
Francesca Benini
Francesco Quagliarella
Chiara Rosignoli
Marco Rosichini
Shirley Genah
Marialuigia Catanoso
Antonella Cardinale
Gabriele Volpe
Marianna Coccetti
Angela Pitisci
Giuseppina Li Pira
Roberto Carta
Barbarella Lucarelli
Francesca Del Bufalo
Valentina Bertaina
Marco Becilli
Daria Pagliara
Mattia Algeri
Pietro Merli
Franco Locatelli
Enrico Velardi
Source :
Haematologica, Vol 999, Iss 1 (2024)
Publication Year :
2024
Publisher :
Ferrata Storti Foundation, 2024.

Abstract

Mucosal-associated invariant T (MAIT) cells are innate-like T-cells implicated in the response to fungal and bacterial infections. Their contribution to restoring T-cell immunity and influencing hematopoietic stem cell transplant (HSCT) outcomes remains poorly understood. We retrospectively studied MAIT-cell recovery in 145 consecutive children and young adults with hematological malignancies undergoing allo-HSCT, between April/2019 and May/2022, from unrelated matched donor (MUD, n=52), with standard graft-versus-host-disease (GvHD) prophylaxis, or HLA-haploidentical (Haplo, n=93) donor after in vitro αβT/CD19-cell depletion, without post-HSCT pharmacological prophylaxis. With a median follow-up of 33 months (12-49), overall survival (OS), disease-free survival (DFS) and non-relapse mortality (NRM) were 79.5%, 72% and 7%, respectively; GvHD-free, Relapse-free Survival (GRFS) was 63%, while cumulative incidence of relapse was 23%. While WWT-cells reconstituted 1-2 years post-HSCT, MAIT-cells showed delayed recovery and prolonged functional impairment, characterized by expression of activation (CD25, CD38), exhaustion (PD1, TIM3) and senescence (CD57) markers, and suboptimal ex vivo response. OS, DFS and NRM were not affected by MAIT-cells. Interestingly, higher MAIT-cells at day+30 correlated with higher incidence of grade II-IV acute GvHD (19% vs 7%, p=0.06). Furthermore, a greater MAIT-cell count tended to be associated with a higher incidence of chronic GvHD (17% vs 6%, p=0.07) resulting in lower GRFS (55% vs 73%, p=0.05). Higher MAIT-cells also correlated with greater cytomegalovirus (CMV) reactivation and lower late blood stream infections (BSI) (44% vs 24%, p=0.02 and 9% vs 18%, p=0.08, respectively). Future studies are needed to confirm the impact of early MAIT-cell recovery on cGvHD, CMV reactivation and late BSI.

Details

Language :
English
ISSN :
03906078 and 15928721
Volume :
999
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Haematologica
Publication Type :
Academic Journal
Accession number :
edsdoj.25f2a926a6bd46bd88584bb02e4a9e44
Document Type :
article
Full Text :
https://doi.org/10.3324/haematol.2023.284649